-
Product Insights
Immunochemistry Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins, and therapeutic drugs. These analyzers are typically offered in modular increments, which can operate independently or simultaneously as a unit. Analyzers covered under this category include chemiluminescence analyzers, immunofluorescence analyzers, and enzyme immunoassay (EIA) analyzers. The immunochemistry analyzers pipeline market research report provides comprehensive information about the immunochemistry analyzers pipeline products with a comparative analysis of the products at various stages of development and information...
-
Thematic Analysis
Digital Marketing Trends in Human Immunodeficiency Virus (HIV)
Gilead’s Biktarvy.com achieved the highest traffic across branded HIV patient sites in the US from April 2021 to March 2022, followed by ViiV's Dovato.com and Gilead’s Descovy.com. The highest proportion of traffic to these sites originated from direct sources, followed by referrals. Websites for several brands, including Descovy, Cabenuva, Truvada, and Pifeltro, had similar levels of high direct traffic, while Janssen’s Symtuza.com had the lowest.
-
Thematic Analysis
Digital Health in Immunology – Thematic Research
Digital technologies are constantly evolving and finding new applications in healthcare. These tools can be used to track health, deliver therapeutic interventions, and contribute to research. They include digital therapeutics (DTx), mobile health, (mHealth), wearable technology, digital biomarkers, telemedicine, virtual reality (VR), and augmented reality (AR). Using search terms relevant to rheumatology, dermatology, and gastroenterology, approximately 2,000 mobile apps were identified from third-party data provider Airnow Data. More than 300 of the apps are for dermatology, followed by gastroenterology and...
-
Thematic Analysis
Remote Patient Monitoring – Opportunities for Pharma – Thematic Research
Remote patient monitoring (RPM) relies on digital health technologies and connected devices to record vital signs and relay data and information to patients, careers, and physicians or healthcare teams. RPM enables clinicians to track patients in real time through a clinician dashboard or directly within a patient’s electronic health record (EHR), allowing timely intervention if necessary. RPM also gives patients more control over their health and a sense of empowerment, while improving health outcomes. The use of RPM has gained...
-
Sector Analysis
Coronavirus Disease 2019 (COVID-19) Impact on the Sales of Immunology Drugs
The global spread of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), throughout 2020 has led to widespread disruption of daily life, leading to national lockdowns in attempts to mitigate the pandemic. Disruptions to healthcare systems and the management of chronic diseases has resulted in patients having difficulty seeing HCPs and receiving treatment, including for autoimmune and inflammatory conditions, especially as many of these immunological disorders require ongoing therapy. Immunological disorders whose treatment has been disrupted include psoriasis, rheumatoid arthritis,...
-
Sector Analysis
Digital Landscape: Ankylosing Spondylitis
The Digital Landscape Ankylosing Spondylitis report analyzes digital activities undertaken by pharma in support of therapies for active Ankylosing Spondylitis (AS)
-
Sector Analysis
Digital Landscape: Psoriatic Arthritis
The Digital Landscape Psoriatic Arthritis report analyzes digital activities undertaken by pharma in support of therapies for active Psoriatic Arthritis (PsA).
-
Sector Analysis
Digital Landscape: Psoriasis
The Digital Landscape Psoriasis report analyzes digital activities undertaken by pharma in support of therapies for moderate-to-severe psoriasis (PsO).
-
Sector Analysis
Digital Landscape: Rheumatoid Arthritis
The Digital Landscape Rheumatoid Arthritis report analyzes digital activities undertaken by pharma in support of therapies for moderate-to-severe rheumatoid arthritis (RA).
-
Sector Analysis
Digital Landscape: Multiple Sclerosis
The Digital Landscape Multiple Sclerosis report analyzes digital activities undertaken by Pharma in support of disease-modifying therapies for Multiple Sclerosis (MS).